Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression? Sharma S, Opyrchal M, Lu X. J Clin Invest 2022;132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sharma S, Opyrchal M, Lu X. Harnessing tumorous flaws for immune supremacy: is miRNA-155 the weak link in breast cancer progression? J Clin Invest 2022;132.
PMID: 36189796